Everlywell, a producer of home tests based in Austin, Texas, for COVID-19 and other illnesses and health issues, raised $ 75 million in addition to a recent $ 175 million round of series D, according to published reports.
The latest funding comes from HealthQuest Capital, an investment fund based in Belmont, Calif., Which focuses on early stage companies. The investment will place HealthQuest managing partner Garheng Kong on Everlywell’s board of directors, according to a Friday Jan.15 tweet from his account.
According to published reports, as the new investment will be used to “provide liquidity” to existing investors, the placement will not change Everlywell’s $ 1.3 billion valuation.
In addition to its $ 109 COVID-19 test, Everlywell sells home test kits for food sensitivities, thyroid issues, metabolic issues, vitamin deficiencies, and other conditions.
The new funding comes six weeks after Everlywell closed a $ 175 …
News Highlights Finance
- According to the source Home Startup COVID Test Everlywell Nets $ 75 M
- Check all news and articles from the Gaming news updates.